Bioventus (BVS) Long-Term Debt Issuances (2020 - 2025)

Bioventus (BVS) has 5 years of Long-Term Debt Issuances data on file, last reported at $13.1 million in Q4 2025.

• For the quarter ending Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to $13.1 million; the trailing twelve-month figure through Mar 2026 stood at $43.1 million (up 187.29% YoY), and the FY2025 full-year result was $45.0 million, changed N/A from the prior year.
• Long-Term Debt Issuances for Q4 2025 stood at $13.1 million, down from $15.0 million in the prior quarter.
• Across five years, Long-Term Debt Issuances topped out at $257.5 million in Q4 2021 and bottomed at -$64.0 million in Q4 2023.
• The 4-year median for Long-Term Debt Issuances is $15.0 million (2022), against an average of $34.1 million.
• The widest annual swing landed in 2021, when Long-Term Debt Issuances surged 625.41%; it then surged 226.67% in 2023.
• A 4-year view of Long-Term Debt Issuances shows it stood at $257.5 million in 2021, then slumped by 96.12% to $10.0 million in 2022, then sank by 740.0% to -$64.0 million in 2023, then soared by 120.46% to $13.1 million in 2025.
• The last three Long-Term Debt Issuances figures came in at $13.1 million (Q4 2025), $15.0 million (Q3 2025), and $15.0 million (Q2 2025), per Business Quant data.

Peer Comparison